Men wait much longer to seek treatment for HIV/AIDS, new global study finds

August 1, 2018 by Françoise Makanda, University of Toronto
Credit: CC0 Public Domain

Men seek and start treatment for HIV/AIDS when they are much sicker compared to women, according to a study by researchers from around the world, including at the University of Toronto's Dalla Lana School of Public Health.

"It's a gender equity issue but not the kind we are used to thinking about," said Paula Braitstein, associate professor of epidemiology at Dalla Lana, who participated in the study along with other world-leading HIV/AIDS researchers.

"Men tend to wait to get tested and seek treatment until they are really sick and cannot ignore it. They face challenges like the culture of hyper-masculinity and not wanting to appear weak or acknowledge multiple sexual partners. It's the stigma and psychosocial challenges they face."

The study, published recently in the Journal of the International AIDS Society, surveyed 715,252 men and women in seven world regions, including North America, South America, Australia and Africa.

"Women tend to get tested voluntarily or when they become pregnant and seek prenatal care. In lower-income countries, women will get tested while accessing care for themselves or for their child, which is part of an integrated process in Kenya," said Braitstein, who also holds a Canadian Institutes of Health Research applied chair.

Leading experts have warned that HIV infections are surging in some parts of the world because of dangerous complacency, with the focus on virus-suppressing treatment taking away attention from basic prevention.

Braitstein, a 25-year veteran in HIV/AIDS research, has experienced this complacency first-hand. "I remember speaking with a 22-year-old Toronto man who didn't understand how HIV is transmitted. I think complacency is related to our failure to educate youth on both HIV and other STIs."

She recalls a time when there were no treatments for HIV/AIDS, which encouraged the need for basic protection. Today, HIV is both a preventable and a manageable chronic disease. While the number of new infections and HIV/AIDS deaths are lower, experts have seen an increase in people on life-saving antiretroviral therapy. At least in high-income settings, Braitstein said, some people at risk and young people are taking it for granted.

The study also found that in some parts of Africa and South America, the majority of people living with HIV/AIDS stayed on the same treatment much longer, sometimes for more than 10 years, compared to their North American counterparts. In fact, 50 per cent of participants surveyed had taken for more than eight years.

While this might be good news because at least on paper the treatment lasts, it may also be because of disparities in access to technologies for monitoring treatment effectiveness and alternatives to switch to, if needed.

"In North America, there's all sorts of testing to see if the virus has developed resistance and specialists are likely to be quick to change treatment, but in most middle- to low-income countries, don't have those options. Expanding third-line treatment or individually tailored regimens is costly."

Health professionals in North America have access to advanced technology and more treatment options. Specialists are also able to monitor the virus and immune system to understand when the virus is more sensitive to a treatment.

For now, Braitstein is eager to see more public engagement on HIV/AIDS prevention.

"I think it's important that more investments are made in virologic monitoring and testing," she said. "We also need more research and innovative programming to engage men to help improve their uptake of, and adherence to, and overcome the pernicious stigma around HIV that continues to persist around the world today."

Explore further: Record three in five HIV-carriers now have access to drugs: UN

More information: Michelle L Giles et al. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA), Journal of the International AIDS Society (2018). DOI: 10.1002/jia2.25149

Related Stories

Record three in five HIV-carriers now have access to drugs: UN

July 18, 2018
Almost three in five people infected with HIV, or 21.7 million globally, took antiretroviral therapy in 2017—a new record for anti-AIDS drug access, the UN's HIV/AIDS agency said Wednesday.

UN warns of AIDS rebound risk as flat funding threatens gains

July 18, 2018
Great strides in preventing AIDS deaths and new infections risk being halted, even reversed, if funding and focus continues to dwindle, the UN warned Wednesday.

'Dangerous complacency' looms over world AIDS meeting

July 20, 2018
Thousands of experts and activists descend on Amsterdam Monday to bolster the battle against AIDS amid warnings that "dangerous complacency" may cause a resurgence of the epidemic that has already killed 35 million people.

'Dangerous complacency' warnings at world AIDS conference

July 23, 2018
A world AIDS assembly opens in Amsterdam on Monday hoping to harness the star power of activists Elton John and Prince Harry to bolster the battle against an epidemic experts warn may yet spiral out of control.

High risk of 'losing control' of AIDS epidemic: experts

July 22, 2018
The AIDS epidemic risks resurging and spiralling out of control unless billions of extra dollars are pumped into prevention and treatment, experts warned Sunday on the eve of a major world conference.

Men at higher risk of dying of AIDS than women: UNAIDS

December 1, 2017
Men are less likely to test for HIV or access antiretroviral therapy and, therefore, are more likely to die of AIDS-related illnesses than women, UNAIDS said on Friday.

Recommended for you

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

Researchers uncover new role of TIP60 protein in controlling tumour formation

October 8, 2018
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting ...

Combination therapy targets latent reservoir of HIV

October 3, 2018
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Anti-integrin therapy effect on intestinal immune system in HIV-infected patients

October 3, 2018
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid ...

No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

October 1, 2018
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.